A quantitative analysis of N-myc downstream regulated gene 2 (NDRG 2) in human tissues and cell lysates by reverse-phase protein microarray

Clinica Chimica Acta

Volumn 387, Issue 1-2, 2008, Pages 84-89

  Park, Mi Young ^a   Choi, Seung Chul ^a   Lee, Hayang Sin ^a   Kim, Daekwang ^a   Baek, Kyoung Eun ^a   Kim, Jong Tae ^a   Lim, Jong Seok ^b   Yeom, Young Il ^a   Chung, Jin Woong ^a   Kim, Jong Wan ^c   Myung, Pyung Keun ^d   Lee, Hee Gu ^a   Kim, Jae Wha ^a   Song, Eun Young ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Sookmyung Women's University   (South Korea)

^c Dankook University College of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Hepatocellular carcinoma; Monoclonal antibody; N myc downstream regulated gene 2; Reverse phase protein microarrary

Indexed keywords

COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; NDRG2 PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL LYSATE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; N MYC DOWNSTREAM REGULATED GENE 2; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE PHASE PROTEIN MICROARRAY; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; BASE SEQUENCE; DNA PRIMERS; HUMANS; POLYMERASE CHAIN REACTION; PROTEIN ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

ARMORACIA RUSTICANA;

EID: 35948983778     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.09.010     Document Type: Article

References (9)

1. Qu X., Zhai Y., Wei H., et al. Characterization and expression of 3 novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229 (2002) 35-44
2. Boulkroun S., Fay M., Zennaro M.C., et al. Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem 277 35 (2002) 31506-31515
3. Choi S.C., Kim K.D., Kim J.T., et al. Expression and regulation of NDRG2 (N-myc downstream regulated gene 2) during the differentiation of dendritic cells. FEBS Lett 553 (2003) 413-418
4. Lusis E.A., Watson M.A., Chicoine M.R., et al. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65 (2005) 7121-7126
5. Hu X.L., Liu X.P., Lin S.X., et al. NDRG2 expression and mutation in human liver and pancreatic cancers. World J Gastroenterol 10 23 (2004) 3518-3521
6. Petricoin E.F., Zoon K.C., Kohn E.C., Barrett J.C., and Liotta L.A. Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov 1 (2002) 683-695
7. Köhler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
8. Shimono A., Okuda T., and Kondoh H. N-myc-dependent repression of ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant. Mech Dev 83 (1999) 39-52
9. Deng Y., Yao L., Chau L., et al. N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer 106 (2003) 342-347